News Stories

FDA approves leadless CRT device for heart failure

EBR Systems has gained U.S. FDA approval for its innovative wireless pacing device for heart failure, the WiSE cardiac resynchronization therapy (CRT) system. The device works with a patient’s existing implant to provide biventricular pacing.

FDA approves leadless CRT device for heart failure

The WiSE cardiac resynchronization therapy (CRT) system. The device works with a patient’s existing implant to provide biventricular pacing.

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Whether newer pacing techniques can mitigate death, LV decline, and HF symptoms in TAVI patients remains to be seen.

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

Despite the randomized trial showing a difference in outcomes, more data are needed before changing practice, says one expert.

‘A new alternative’: Tiny pacemakers for infants show early promise

Small pacemakers built specifically for infants are both safe and effective, according to a new analysis published in Circulation: Arrhythmia and Electrophysiology